최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of veterinary clinics = 한국임상수의학회지, v.38 no.5, 2021년, pp.215 - 220
Chae, Dong-Jin (College of Veterinary Medicine, Chungnam National University) , Han, Sung-Hyun (College of Veterinary Medicine, Chungnam National University) , Song, Kunho (College of Veterinary Medicine, Chungnam National University)
The purpose of this study was to investigate the correlation between vertebral left atrial size (VLAS) and NT-proBNP levels. Sixty-three dogs with myxomatous mitral valve disease (MMVD) were recruited for this study. The MMVD group was classified according to the ACVIM stage based on medical history...
Abbott JA. Acquired valvular disease. In: Tilley L, Smith F, Oyama M, Sleeper M, editors. Manual of canine and feline cardiology. 4th ed. St. Louis: Elsevier Sounders. 2008: 110-138.
Cornell CC, Kittleson MD, Della Torre P, Haggstrom J, Lombard CW, Pedersen HD, et al. Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med 2004; 18: 311-321.
Cote E, MacDonald KA, Meurs KM, Sleeper MM. Feline cardiology. Arnes: Wiley-Blackwell. 2011: 69-75.
de Lima GV, Ferreira FDS. N-terminal-pro brain natriuretic peptides in dogs and cats: a technical and clinical review. Vet World 2017; 10: 1072-1082.
Ishikawa T, Tanaka R, Suzuki S, Saida Y, Soda A, Fukushima R, et al. Daily rhythms of left atrial pressure in beagle dogs with mitral valve regurgitation. J Vet Intern Med 2009; 23: 824-831.
Keene BW, Atkins CE, Bonagura JD, Fox PR, Haggstrom J, Fuentes VL, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med 2019; 33: 1127-1140.
Lamb CR, Wikeley H, Boswood A, Pfeiffer DU. Use of breed-specific ranges for the vertebral heart scale as an aid to the radiographic diagnosis of cardiac disease in dogs. Vet Rec 2001; 148: 707-711.
Latini R, Masson S. NT-proBNP: a guide to improve the management of patients with heart failure. EJIFCC 2013; 24: 78-84.
Malcolm EL, Visser LC, Phillips KL, Johnson LR. Diagnostic value of vertebral left atrial size as determined from thoracic radiographs for assessment of left atrial size in dogs with myxomatous mitral valve disease. J Am Vet Med Assoc 2018; 253: 1038-1045.
Mikawa S, Nagakawa M, Ogi H, Akabane R, Koyama Y, Sakatani A, et al. Use of vertebral left atrial size for staging of dogs with myxomatous valve disease. J Vet Cardiol 2020; 30: 92-99.
Ogawa M, Hori Y, Kanno N, Iwasa N, Toyofuku T, Isayama N, et al. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease. J Vet Med Sci 2021; 83: 705-715.
Park JS, Park JH, Seo KW, Song KH. Correlation between NT-proB-NP and lipase levels according to the severity of chronic mitral valve disease in dogs. J Vet Sci 2019; 20: e43.
Silverstein DC. Small animal critical care medicine. 2nd ed. St. Louis: Elsevier Sounders. 2015: 213-217.
Strohm LE, Visser LC, Chapel EH, Drost WT, Bonagura JD. Two-dimensional, long-axis echocardiographic ratios for assessment of left atrial and ventricular size in dogs. J Vet Cardiol 2018; 20: 330-342.
Vezzosi T, Puccinelli C, Tognetti R, Pelligra T, Citi S. Radiographic vertebral left atrial size: a reference interval study in healthy adult dogs. Vet Radiol Ultrasound 2020; 61: 507-511.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.